Vetter Pharma Fertigung GmbH & Co. KG (Langenargen Eisenbahnstrasse)
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Germany
- Registered address
- Eisenbahnstrasse 2-4, Langenargen, Baden-Wuerttemberg 88085, Germany (DEU)
- Operations here
- analysismanufacture
- FDA identifiers
- FEI 3002808846 · DUNS 344217323
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2022-05-24
- NAIDrug Quality Assurance2019-09-13
- NAIDrug Quality Assurance2018-09-21
- VAIBlood and Blood Products2017-11-10
- VAIDrug Quality Assurance2016-04-26
- NAIDrug Quality Assurance2014-02-20
- NAIDrug Quality Assurance2012-07-17
- VAIDrug Quality Assurance2010-04-01
Drugs this plant is listed as making
7 distinct drugs across 19 products name this site in their FDA label.
- Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtlBioverativ Therapeutics Inc.
- certolizumab pegolUCB, Inc.
- DaratumumabJanssen Biotech, Inc.
- fitusiranGenzyme Corporation
- lumasiranAlnylam Pharmaceuticals, Inc.
- nipocalimab-aahuJanssen Biotech, Inc.
- risperidoneJanssen Pharmaceuticals, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.